Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
23.80
+0.76 (3.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dianthus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -67.09 | -43.56 | -28.48 | -13.11 |
| Depreciation & Amortization | 0.44 | 0.36 | 0.15 | - |
| Loss (Gain) From Sale of Investments | -4.12 | -1.42 | -0.61 | - |
| Stock-Based Compensation | 9.7 | 2.9 | 1.52 | 0.06 |
| Change in Accounts Receivable | -0.77 | 0.75 | 0.07 | -1.01 |
| Change in Accounts Payable | 7.51 | 0.66 | 2.28 | 4.92 |
| Change in Unearned Revenue | -0.11 | -0.06 | 0.89 | - |
| Change in Other Net Operating Assets | -8.16 | 3.5 | -4.89 | -0.77 |
| Operating Cash Flow | -62.59 | -36.86 | -29.07 | -9.9 |
| Capital Expenditures | -0.08 | -0.11 | -0.14 | -0.03 |
| Investment in Securities | -271.86 | 20.36 | -59.68 | - |
| Investing Cash Flow | -271.94 | 20.25 | -59.82 | -0.03 |
| Short-Term Debt Issued | - | 0.38 | - | - |
| Total Debt Issued | - | 0.38 | - | - |
| Short-Term Debt Repaid | - | -0.38 | - | - |
| Total Debt Repaid | - | -0.38 | - | - |
| Issuance of Common Stock | 230.61 | 0.01 | - | - |
| Other Financing Activities | -19.53 | 133.57 | -3.32 | -0.09 |
| Financing Cash Flow | 211.08 | 133.57 | 96.68 | 14.91 |
| Net Cash Flow | -123.45 | 116.97 | 7.79 | 4.98 |
| Free Cash Flow | -62.67 | -36.97 | -29.21 | -9.94 |
| Free Cash Flow Margin | -1167.98% | -1308.24% | -455.18% | -673.24% |
| Free Cash Flow Per Share | -2.22 | -7.17 | -33.41 | -2.48 |
| Levered Free Cash Flow | -43.81 | -22.81 | -19.31 | - |
| Unlevered Free Cash Flow | -43.81 | -22.81 | -19.31 | - |
| Change in Net Working Capital | 2.05 | -4.15 | 2.27 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.